Regeneron Joins String of Pharma Companies Subpoenaed Over Pricing Programs
Regeneron Pharmaceuticals received a subpoena last month as part of a Department of Justice investigation into the nonprofit organizations that play a key role in reducing the sticker price of some drugs.
Source: Drug Industry Daily